phenylpropanolamine has been researched along with Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pappalardo, A; Patti, F; Reggio, A | 1 |
| Bard, RJ; Casey, AR; Ethans, KD; Nance, PW; Schryvers, OI | 1 |
1 review(s) available for phenylpropanolamine and Multiple Sclerosis
| Article | Year |
|---|---|
[Management of neuropathic bladder in multiple sclerosis].
Topics: Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Botulinum Toxins; Capsaicin; Cresols; Diterpenes; Electric Stimulation Therapy; Humans; Multiple Sclerosis; Muscarinic Antagonists; Phenylpropanolamine; Prognosis; Quality of Life; Time Factors; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urodynamics | 2004 |
1 trial(s) available for phenylpropanolamine and Multiple Sclerosis
| Article | Year |
|---|---|
Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity.
Topics: Adult; Benzhydryl Compounds; Cresols; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Multiple Sclerosis; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Spinal Cord Injuries; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Incontinence; Xerostomia | 2004 |